University Hospital Cologne, Department of Internal Medicine I, Clinical Study Centre II for Infectious Diseases
University Hospital Cologne, Department of Internal Medicine I, Clinical Study Centre II for Infectious Diseases
Cologne, North Rhine-Westphalia, Germany1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. | Bacterial Infections and Mycoses, Fungemia, Infections, Inflammation, Invasive Fungal Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Torulopsis, candidemia, candidiasis, candidiasis, invasive, fungal infectious disease | Recruiting | Phase 3 | 2026-09-14 | NCT05421858 |